Brainsway Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on August 12, 2020, by Brainsway Ltd., a foreign private issuer based in Jerusalem, Israel, serves as a cover document for the company's Second Quarter 2020 financial results and operational highlights. The filing indicates the company reports annually on Form 20-F.
Financial Metrics
The provided text is a cover sheet and exhibit index. It does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The actual financial figures are contained in the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide details on material changes versus the prior comparable period. It only references the existence of a report containing these results.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in the provided text. These elements are expected to be found within the attached Exhibit 99.1.
Key Facts for Investor Verification
- Verify the specific revenue and net loss figures for Q2 2020 in the attached Exhibit 99.1 press release.
- Confirm the company's cash position and burn rate as of June 30, 2020, which are not listed in this cover document.
- Review the operational highlights regarding the company's core product, the NeuroStar TMS Therapy System, in the full report.
- Check for any updates on regulatory approvals or clinical trial results mentioned in the full operational highlights.